Abilify is a new antipsychotic medication approved by the US Food and Drug Administration in November 2002 for the treatment of schizophrenia. This drug treats for symptoms that are also found in major manic episodes of bipolar disorder and in schizoaffective disorder. Two things that appear to distinguish Abilify from other antipsychotic medications are a cleaner side-effect profile and a positive effect on depression ... Read More
Comments
No comments yet. Leave a Comment

